Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT03580395 Enrolling by invitation - Breast Cancer Clinical Trials

Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer

Start date: June 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

To verify the role of apatinib in neoadjuvant therapy for breast cancer, the investigators designed a prospective, randomized, parallel-controlled phase II/III trial, to investigate the efficacy and safety of apatinib combined with TP (paclitaxel + cisplatin) or TP regimen alone as neoadjuvant therapy for stage II-III breast cancer treatment. 100 cases of eligible patients were diagnosed by core needle biopsy and immunohistochemistry, with the molecular subtypes of triple-negative, HER2+ or Luminal B, evaluated by pathological complete remission (pCR), objective response rate (ORR), adverse events, disease free survival (DFS) and OS, aiming at providing a new way for neoadjuvant therapy in breast cancer and anti-angiogenic treatment of malignant tumors.

NCT ID: NCT03580109 Not yet recruiting - Breast Cancer Clinical Trials

Spa Therapy of Upper Limb Lymphoedema

THERMOEDEME
Start date: September 2018
Phase: N/A
Study type: Interventional

The lymphoedema is a chronic disease caused by an insufficiency of lymphatic system. In France, 100 000 persons are disabled by this disease. The most classic form is the "swollen arm" which affects the women after surgery and radiotherapy treatments in breast cancer. The lymphoedema is a traditional phlebology indication in spa therapy. The spa therapy linked with therapeutic education could constitute a favorable environment for the treatment of arm lymphoedema post breast cancer treatments.

NCT ID: NCT03579979 Enrolling by invitation - Breast Cancer Clinical Trials

Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG

Start date: May 31, 2018
Phase: N/A
Study type: Interventional

This clinical trial is a prospective, multicenter, self-controlled clinical study. In order to meet the requirements of this plan, 130 breast cancer patients need the sentinel lymph node biopsy with novel near-infarred fluorescence imaging system produced by Beijing digital precision medical technology co., LTD. The fluorescence molecular imaging of indocyanine green (ICG) on imaging detection and the control group, routine medical using methylene blue test .The safety and efficacy of fluorescence and staining in sentinel lymph node biopsy of breast cancer were compared.

NCT ID: NCT03579524 Not yet recruiting - Breast Cancer Clinical Trials

Comparison of Erector Spinae Plane Block With Serratus Anterior Plane Block for Breast Surgery

Start date: July 15, 2018
Phase: N/A
Study type: Interventional

Breast cancer is by far the world's most common cancer among women and the most common cause of female death from cancer worldwide. It's worldwide incidence is 43.4 in 100.000 while in Egypt is 48.8 in 100.000. One of the most common surgical procedures for it is modified radical mastectomy (MRM), It is account for 31% of all breast surgery cases. Post‑mastectomy pain is a big problem affecting the outcome of surgery. It was used to be managed by opioids which may lead to many side effects such as nausea, vomiting, ileus, over sedation and respiratory depression. Chronic pain syndrome (phantom breast pain, paraesthesias, and intercostobrachial neuralgia) may be developed due to inadequate pain control. So many regional analgesic techniques have been developed for effective pain control. The safest and easiest is local wound infiltration with local anesthesia but the duration of action is limited. Intercostal nerve block and interpleural block are effective, but there is a fear of pneumothorax and transient Horner's syndrome. Thoracic epidural analgesia is not preferred however it's efficacy because of possible neurological and hemodynamic side effects. The gold standard now is thoracic paravertebral block (PVB) which provide effective analgesia with minimal hemodynamic derangement but it carries a risk of pneumothorax in addition to slightly complex technique. Ultrasound‑guided interfascial plane blocks such as pectoral nerve (PECS) block type 1 and 2 , serratus anterior plane block (SAPB) and erector spinae plane block (ESP) which is a recent block newly described for various surgeries for postoperative analgesia have also been reported as alternatives, with the advantages of simplicity, ease of performance and fewer complications. there is no sufficient Randomized controlled trails that assess the effectiveness and safety of erector spinae plane block ESPB in controlling post mastectomy pain This study compares the analgesic efficacy of ultrasound‑guided erector spinae plane block (ESPB) and serratus anterior plane block (SAPB) in patients undergoing MRM with axillary dissection.

NCT ID: NCT03578484 Recruiting - Breast Cancer Clinical Trials

Breast Aesthetics by Three Dimensional Measures

Start date: May 13, 2016
Phase:
Study type: Observational

Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). These early and important papers still strongly influence the view of the aesthetics of the breast despite the lack of individualisation and proportion. To create satisfying results for specific patients, optimal proportions angles and relative measures are needed for each patient. The study will clarify theses measures and provide important guidelines for surgeons.The data will also help define optimal proportional aesthetics in the individual patient. The concept of universal beauty is unrealistic. It has always been taken for granted that aesthetic values from all cultures are similar. Using 3D scanning on volunteers of youthful age offers a complex set of data that may distinguish fine differences in aesthetic ideals in different cultures. Little is known about how life events and life-style factors affect breast aesthetics. To follow a population with 3D scans over 5, 10 and 15 years will allow aesthetic ratings to be correlated with life events such as pregnancy, childbirth, breast-feeding and life style factors such as smoking. The study will improve the understanding of breast aesthetics in general, in different cultures and in relation to life events and life style factors. No similar studies have previously been performed.

NCT ID: NCT03578380 Recruiting - Breast Cancer Clinical Trials

Supermicrosurgery for Breast Cancer Survivors With Lymphedema.

Start date: January 26, 2016
Phase: N/A
Study type: Interventional

A randomised prospective investigation of volume and quality of life results with lymphovenous anastomosis in patients with unilateral arm lymphedema after breast cancer using Indocyanine Green lymphangiography and MD Anderson Staging.

NCT ID: NCT03576521 Completed - Breast Cancer Clinical Trials

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Start date: May 13, 2015
Phase: Phase 2
Study type: Interventional

The purpose is to determine the efficacy of the nutritional supplement Ocoxin-Viusid oral solution (OV) in the reduction of acute toxicity of Chemotherapy (CT) treatment with patients with breast carcinoma. A randomized, double-blind phase II clinical trial was designed, with a sample of 120 patients distributed in 2 arms: 60 patients will receive the CT treatment plus the OV, 60 will receive CT plus OV placebo. The OV / placebo will be administered before, during and 3 weeks after the conclusion of the CT. A better tolerance to the treatment is expected with the addition of the nutritional supplement.

NCT ID: NCT03575520 Completed - Breast Cancer Clinical Trials

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Start date: June 7, 2016
Phase: Phase 2
Study type: Interventional

This is a prospective, single arm study, which is examining doxorubicin and cyclophosphamide (AC) once every 2 weeks with pegteograstim support in Korean early breast cancer.

NCT ID: NCT03575260 Recruiting - Breast Cancer Clinical Trials

500mg Fulvestrant Versus Exemestane in MBC

Start date: July 1, 2017
Phase:
Study type: Observational

500mg Fulvestrant versus Exemestane in MBC

NCT ID: NCT03573804 Not yet recruiting - Breast Cancer Clinical Trials

The Prone to Supine Breast MRI Trial

Start date: June 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a supine MRI obtained immediately after a standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast material, would be of sufficient quality to allow the Radiologist to define the tumor edges ("segment" the tumor) so that a 3-D image of the tumor can be generated to form a BCL.